Targanta Therapeutics' P2P Acquisition

Targanta Therapeutics raised a round of funding on February 26, 2009. Investors include The Medicines Company.

Targanta Therapeutics, Inc. (NASDAQ:TARG) is a biotechnology company developing and commercializing antibacterial drugs to treat serious infections in the hospital setting. Targanta's lead drug candid…

Articles about Targanta Therapeutics' P2P Acquisition: